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Abstract 
 
Background: There is increasing evidence that adipokines e.g. leptin, adiponectin, adipsin and resistin, are 
involved in diseases of the central nervous system. Leptin has displayed an anticonvulsant effect in 
experimental seizure models. Therefore, we examined adipokine levels in epilepsy patients after a seizure 
in a controlled environment taking into account diurnal variations in both seizures and adipokines. 
Methods: The concentrations of leptin, adiponectin, adipsin and resistin were measured in serum in 51 
patients with epilepsy [temporal lobe epilepsy (TLE, n=23), extratemporal lobe epilepsy (XLE, n=24), and 
idiopathic generalized epilepsy (IGE, n=4)] before and after the first verified seizure (IS; index seizure) 
during inpatient video-EEG monitoring. 
Results: Leptin concentrations exhibited a significant increase at 3, 6, 12 and 24 h time points after the IS as 
compared to the baseline (p < 0.001; Wilcoxon signed ranks test). The levels of leptin were increased after a 
focal seizure in patients with impaired awareness (p<0.001; Friedman's test) and focal to bilateral tonic-
clonic seizures (p<0.05; Friedman's test), but not in patients with aware seizures. Resistin concentrations 
were also increased 12h after the IS (p < 0.05, Wilcoxon signed ranks test).  Further analyses demonstrated 
that the timing of the seizures was not randomly distributed but coincided with time points at which there 
were low leptin plasma levels reflecting the diurnal variation in leptin concentrations i.e. highest 
concentrations around midnight and lowest values between morning and noon. 
Conclusion: This study demonstrates the significance of diurnal variation in an immunoregulatory molecule, 
i.e. leptin, when investigating the effect of a precipitating event, e.g. a seizure 
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1. Introduction 

In addition to specializing in lipid handling and energy balance regulation, white adipose tissue cells 
produce cytokines and cytokine-like hormones called adipokines. There are several adipokines e.g. leptin, 
adiponectin, adipsin and resistin; these have many properties including immunoregulatory functions. Many 
adipokines have pro- or anti-inflammatory effects and they co-operate with other cytokines in determining 
the overall responses to inflammatory reactions. [1] Recent findings have suggested that adipokines may 
play a role in the pathogenesis of certain central nervous system diseases, such as multiple sclerosis [2], 
Alzheimer's disease [3], [4], autism [5], and Rett syndrome [6]. On the other hand, there is evidence that 
resistin may contribute to the pathogenesis of brain injury and elevated resistin concentrations have been 
linked to a poorer outcome [7], [8], [9]. Both leptin [10], [11] and adiponectin [12], [13] have exhibited 
beneficial properties in animal models of epilepsy; the effects of resistin and adipsin have not been studied 
in these models.   
 
In a recent study, we assayed cerebrospinal fluid (CSF) and plasma levels of leptin, adiponectin and adipsin 
after either provoked or unprovoked generalized tonic-clonic seizures (GTCS) or focal to bilateral tonic-
clonic seizures (FBTCS) in 13 female patients and seven controls within 24 h after the seizure onset. Leptin 
plasma levels correlated negatively with the time of sample withdrawal, i.e. the longer the time interval 
between the seizure and the sample, the lower the patient’s leptin levels. Interestingly, plasma adiponectin 
levels were significantly elevated after a seizure episode. [14] 
 
The secretion of adipokine follows a diurnal variation. The main circadian pacemaker regulating hormone 
secretion is located in the suprachiasmatic nucleus of hypothalamus [15] Secondary circadian clocks are 
located in many peripheral organs, such as adipose tissue and liver.  Sleep rhythms, meal rhythms, the 
amount of light and metabolic activity also affect the circadian variation of hormone secretion along with 
clock genes and secondary clocks [15], [16], [17]. 
Earlier studies have shown that the secretion of the most relevant adipokine with respect to epilepsy i.e., 
leptin, also follows a distinctive diurnal variation. The highest leptin concentrations of plasma have been 
measured at or immediately after midnight with nadir concentrations being assayed in the morning up until 
midday. [18] 
 
Furthermore, the occurrence of seizures in specific types of epilepsies can follow a -specific 24-hour pattern 
with a non-random distribution. Circadian or sleep–wake related variations in the levels of different 
hormones, neuromediators and body temperature are potentially factors that could contribute to the 
fluctuations in neuronal excitability and the propensity for seizure occurrence. It has been recognized that 
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there is a 24-hour rhythmicity in seizure distribution in certain types of epilepsy, although there are rather 
few studies investigating this topic. [19] 
 
This prompted us to further evaluate the seizure-induced changes of adipokines in a controlled video-EEG 
(VEEG) setting. The aims of this study were 1) to investigate whether these recently discovered functions of 
adipokines in experimental models can be detected in human epilepsy, 2) to assess changes in adipokine 
levels in well-characterized human focal or generalized epileptic seizures, 3) to correlate these changes 
with the epileptic syndrome and the localization or lateralization of the seizure focus and 4) to address the 
significance of the diurnal variation in epileptic seizures and concentrations of the adipokines 
 
2. Materials and methods 
 
2.1. The classification of patients 
Fifty-one consecutive patients with refractory focal epilepsy admitted to the VEEG monitoring unit of the 
Tampere University Hospital were examined in this study. The study protocol was approved by the Ethics 
Committee of the Tampere University Hospital, and all of the patients provided written informed consent.  
  
All patients underwent continuous VEEG monitoring lasting for four days to obtain an electroclinical 
characterization of their seizures as part of the routine clinical evaluation for possible epilepsy surgery. Ictal 
scalp recordings were collected using synchronous digital video and 24 channel standard bipolar EEG. 
Electrodes were placed according to the International 10-20 System with additional mastoid and anterior 
cheek electrodes. All patients underwent a diagnostic brain MRI examination on a 1.5 (General Electric, 
Sigma HD, Milwaukee,Wisconsin, USA) or 3.0 (Siemens Healthcare, Magnetom Trio A Tim system 3T, 
Erlangen, Germany) Tesla device. Seizures were classified according to the ILAE diagnostic criteria [20]. 
Anticonvulsant medication was discontinued in a stepwise fashion during the monitoring period under the 
supervision of the staff epileptologist.  
 
The localization of the seizure focus was recorded and seizures were categorized as focal aware seizures 
(FAS), focal impaired awareness seizures (FIAS), focal to bilateral tonic-clonic seizures (FBTCS) or 
generalized tonic-clonic seizures (GTCS). The first unequivocally verified seizure during the VEEG monitoring 
was considered as the index seizure (IS). All other seizures after the index seizure during the next 24 hours 
were also registered. Based on the findings in the VEEG recordings and MRI, 23 patients had temporal lobe 
epilepsy (TLE), 24 patients had extratemporal lobe epilepsy (XLE) (21 frontal lobe, two parietal lobe and one 
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multilobar epilepsy) and four patients had idiopathic generalized epilepsy (IGE). Seven patients were 
receiving monotherapy, 43 were being treated with polytherapy (the mean number of medications was 
2.37), and one patient had no medication. In addition to antiepileptic drugs (AEDs), 4 patients were being 
treated with vagus nerve stimulation (VNS). One female patient with right hippocampal sclerosis was 
monitored twice during an interval of 23 months. Clinical data of these three groups of patients are shown 
in Table 1. The seizure burden was assessed by the total duration of seizures recorded during the 24h 
sampling period.  

2.2. Plasma sampling and biochemical analyses 
Plasma samples were collected at the onset of  VEEG recording and daily in the morning until patients had 
their first verified seizure (IS; index seizure) and at 3, 6, 12 and 24 hours after the IS. The final sample 
collected before the IS was the baseline sample. The samples were stored at -70 oC until analyzed. Plasma 
concentrations of adiponectin, adipsin, leptin and resistin were determined by enzyme-linked 
immunosorbent assay (ELISA) with commercial reagents (DuoSet ELISA, R&D Systems Europe Ltd, 
Abingdon, U.K).  


3. Statistical analysis   
The difference between basal levels of adipokines (between study groups) was tested using non-parametric 
Kruskal-Wallis test or Mann-Whitney test, and the difference in adipokine levels at different time points 
was tested using a non-parametric related samples test (Wilcoxon signed ranks test or Friedman's test). The 
correlation between numeric parameters was tested using Pearson’s correlation test. All statistical analyses 
were performed using SPSS 17.0 software. 

4. Results

4.1. Seizures  
The mean number of seizures (including IS) in the TLE group was 2.6 (range: 1-9) and in the IGE group, it 
was 1.3 (range: 1-2). In three patients with XLE, 100 or more seizures were recorded during a 24-h period 
(range: 100-400).  After excluding these 3 patients, the mean number of seizures in this group was 5.4 
(range: 1-18). Seven patients had only brief seizures during the sampling period. The mean (seconds±SD) 
duration of the index seizure in TLE was 405±1491 (median 77), in XLE 57±73 (median 26) and in IGE it was 
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66±4 (median 66). The mean seizure burden (seconds±SD) in the TLE group was 549±1575, in the XLE group 
it was 1609±5429 and 81±31 in the IGE group. 

4.2. The baseline levels of the adipokines 
There were no –significant differences in the baseline levels of adipsin, leptin or adiponectin between 
different types of epilepsy (TLE, XLE and IGE). The baseline levels of resistin, however, displayed a trend 
towards a difference between the epilepsy syndromes (p = 0.053; Kruskal Wallis test) with the highest 
levels being found in IGE, with the TLE patients exhibiting the lowest baseline levels. The baseline levels of 
leptin correlated positively with BMI (r=0.46; p < 0.001; Pearson correlation), but there was no correlation 
between adiponectin levels and BMI (r= -0.287; Pearson correlation). There was no association between 
the baseline levels of any adipokine and the patient’s age, seizure lateralization, duration of epilepsy, 
duration of index seizure or seizure frequency. The baseline levels of adiponectin (p<0.01, Mann-Whitney 
test) and leptin (p<0.05, Mann-Whitney test) were higher in female patients. 

4.3. Seizure related analysis; the postictal levels of adipokines 
First, the adipokine concentrations were analysed taking into consideration only the relation to seizures 
without accounting for diurnal variation. According to this analysis, the leptin concentrations increased in 
the 3h to 24 h time points after the index seizure as compared to the baseline (p < 0.001; Wilcoxon signed 
ranks test; Table 2).  Leptin levels were also related to the severity of seizure types (Fig. 1); they were 
significantly increased after both FIAS  (p<0.001; Friedman's test) and FBTCS (p<0.05; Friedman's test), but 
not after FAS (Fig. 1). 
 
There was also an increase in postictal plasma levels of resistin; this elevation was statistically significant at 
the 12h time point (p < 0.05, Wilcoxon signed ranks test); it was statistically significant only in patients with 
TLE (p< 0.01; Wilcoxon signed ranks test), but not in  those with XLE. Adipsin and adiponectin 
concentrations remained unchanged at the different time points (Table 2). There was no association 
between postictal levels of adipsin, adiponectin or resistin and the seizure type.  Plasma concentrations of 
adipsin, adiponectin or leptin were not found to be related to the epilepsy syndrome (TLE, XLE or IGE) or 
lateralization 

4.4. Diurnal variation related analysis; seizure and epilepsy types 
When classified according to seizure types, out of 51 index seizures, 5 were FAS, 36 FIAS and 10 TCS. When 
classified according to epilepsy types, 4 patients had IGE, 23 had TLE with the remaining 24 having XLE. 
There was a diurnal variation with regard to both the different seizure and epilepsy types. The patients with 
7 
 
TCS had 20% of the index seizures in the morning, 40% in the late afternoon/evening and 40% during the 
night. In contrast, patients with impaired awareness seizures experienced 53 % of their seizures in the 
morning, 33% in the late afternoon/evening and only 14% during the night. (Table 3) 
 
The baseline sample was the blood sample taken when patients were admitted to the VEEG unit on the day 
of arrival which occurred for practical reasons during the afternoon, if the patient did not experience a 
seizure during the first day, the second blood sample was taken in the morning of the second day. The 
sample taken before the index seizure was defined as the baseline sample. Most of the baseline samples 
were collected between 08:00 and 12:00. The second largest numbers of samples were collected between 
12:00 and 15:00. The patients with FIAS and FAS had more seizures during the day of arrival  leading to a 
difference in timing of the baseline samples: FAS 20% morning and 80% afternoon,  FIAS 71% morning and 
19% afternoon, TCS 80% morning and 20% afternoon. (Table 3) 

4.5. Diurnal variation related analysis; adipokine concentrations  
Absolute values of leptin vary considerably according to gender and BMI, therefore the analysis was 
conducted by calculating the relative percentage change of leptin levels in comparison to the determined 
baseline level. This enables the results to be evaluated regardless of gender or BMI. 
 
When leptin concentrations were measured after the seizures, the highest concentrations were observed 
around midnight with the lowest values detected between morning and midday. Even after a seizure, 
relative leptin concentrations followed their diurnal variation almost without exception. (Fig. 2) 
 
Patients were categorized by the time of the index seizure into three different groups when analyzing the 
collected data of leptin concentrations during the day. Group 1 index seizure was at 06:00-14.00, group 2 
between 14:00-22:00 and group 3 between 22:00-06:00. Group 1 had their postictal sample collection 
during evening and midnight. An increase in the relative leptin concentrations could be detected around 
midnight with group 1. Group 2 sample collection was conducted during evening and morning. They 
exhibited an initial small increase in leptin levels, but then they started to decline. Group 3 sample 
collection started after midnight: towards the morning hours, a strong decrease could be observed 
followed by a strong increase towards the next midnight. (Fig. 2) 
 
Even TCS follows this diurnal variation i.e. when examined separately in patients who were suffering from 
TCS, the changes of leptin concentrations could be seen to follow the normal diurnal variation. Even if 
gender and BMI were taken into account, the results still remained the same. The lowest leptin 
concentrations occurred around 10:00 in the morning with the highest levels being detected around 
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midnight. Leptin concentrations were not influenced by gender, BMI and the type of seizure, instead the 
variation in the leptin concentration mainly followed a diurnal pattern. (Fig. 3) 
5. Discussion 
 
The major finding emerging from our study is that there is a diurnal variation in both leptin concentrations 
and seizure types when assessing the influence of epileptic events on adipokine responses. We have 
previously reported the effects of epileptic seizures on various biomarkers reflecting neuronal plasticity 
without taking acoount of major diurnal patterns [21]. If analysed only in relation to seizure occurrences, 
then the results would be totally misleading. Our recent results emphasize the importance of taking into 
account all possible confounding factors when analyzing the impact of a seizure on a given biomarker.  
 
When adipokine changes were only evaluated in relation to seizures, it appeared that there was a 
significant elevation in the leptin concentrations after the baseline seizure. There was some change in 
resistin concentrations, but the effect was only marginal but levels of neither adiponectin nor adipsin were 
affected. There seemed to be even a logical difference in terms of seizure severity; the response was fastest 
in TCS with a change of similar magnitude but more delayed after impaired awareness seizures. With the 
mildest seizure types (FAS), there were only small and transient changes. However after taking into 
consideration the timing of the index seizure, then all these effects disappeared, highlighting the major 
influence of diurnal variation in determining the leptin concentrations.  
 
In previous studies, the lowest concentrations of plasma leptin were measured between 08.00-10.00 and 
the highest concentrations between 01.00-.04.00 i.e. there is a distinct circadian variation [18]. In our 
study, the highest concentrations were found around midnight with the lowest concentrations detected 
during morning and around midday (Fig. 3). We conclude that the leptin concentrations adhere to the 
normal diurnal variation even in the presence of epileptic seizures. 
 
The second confounding factor is related to differences in diurnal variation of different seizure and epilepsy 
types. In our study, the patients with TCS experienced more events in the night-time or late 
afternoon/evening and differed in this respect from individuals with impaired awareness seizures. There 
was even a difference in their baseline levels, reflecting the number of seizures in the different seizure 
types. The patients with FIAS and FAS suffered more seizures during the day of arrival, leading to a bias in 
the timing of baseline samples as compared with TCS. If the baseline sample was drawn in the afternoon, 
the possibility of determining a higher leptin concentration was greater as compared with a sample taken in 
the morning, leading to a smaller change between baseline and seizure related samples.  
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Prior studies have shown that some epileptic seizure types can follow distinctive circadian variation. In a 
VEEG study, a non-uniform seizure distribution was observed in seizures arising from the temporal lobe 
(mesial temporal lobe and neocortical temporal lobe), with two peaks observed in both 3- and 4-hour bins: 
10:00–13:00/16:00–19:00 and 08:00–12:00/16:00–20:00 respectively. In contrast, no specific 24-hour 
pattern was identified in seizures with an extratemporal location. [19] 
 
There are some experimental and clinical studies suggesting a possible role for the adipokines in seizure-
related neuronal plasticity. For example, leptin has displayed an anticonvulsant effect in different 
experimental seizure models [10], [11]. Adiponectin has been demonstrated to possess anti-inflammatory 
properties and also to be neuroprotective in animal models of seizures [12], [13]. In experimental studies, 
there is the possibility of directly measuring the adipokine concentrations in the brain whereas in humans, 
most often only plasma samples will be available for analysis, such as in our case with VEEG monitoring. 
However, in our present study, the results revealed that it was the diurnal variation, not the presence of 
the epileptic seizures, which explained the changes of leptin concentrations in plasma.  
 
In conclusion, the changes in the leptin concentrations during the day are not affected by seizures, but 
instead adhere to a diurnal rhythm. This study emphasizes the importance of taking into account the 
diurnal variation of immunoregulatory molecules, when studying their correlation with some pathological 
process, for example with epileptic seizures, which also occur in a non-random temporal manner 
depending on the specific seizure type. 
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Appendix 
 
Table 1. Clinical characteristics of patients in video-EEG. 
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Table 2. Concentrations of four adipokines in 51 patients at baseline, and repeated measurements 
at 3, 6, 12, and 24 hours after index seizure, values are median ± SD.  

Baseline 3h 6h  12h 24h 
Leptin (ng/ml) 
Resistin (ng/ml)     
Adiponectin (μg/ml)     
Adipsin (μg/ml)     

*** P<0.001, *p<0.05 Wilcoxon Signed Ranks Test (compared to baseline) 
 
 
 
 
 
Table 3. The number of seizure types and epilepsy types classified according to the time of 
baseline sample and by the time of index seizure. Baseline samples are missing from two (2) XLE. 
TCS (tonic-clonic seizures) includes both GTCS and FBTCS. 
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Figure 1. The mean change in leptin levels (Δ leptin) is presented according to the different seizure 
types. Error bars represent standard error of mean (SEM). Abbreviations: FAS: focal aware 
seizures; FIAS: focal impaired awareness seizures; TCS: tonic-clonic seizures (includes FBTCS: focal 
to bilateral tonic-clonic seizures and GTCS: generalized tonic-clonic seizures). The absolute levels 
of leptin were significantly elevated after FIAS (p < 0,001; Friedman’s test) and TCS (p < 0,05; 
Friedman’s test), but not after FAS. 
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Figure 2. The change percentage of leptin according to the time of the index seizure as determined 
in the 3-hour, 6-hour, 12-hour and 24-hour samples. 
 
  
15 
 
Figure 3. Development of leptin concentration in the TCS-group expressed as a percentage 
change. Three-hour, 6-hour, 12-hour and 24-hour samples are proportioned to the baseline-
sample. Grey colour indicates women and black men. The dashed line indicates those patients 
who had BMI ≥ 25. The continuous line indicates those patients who had BMI < 25. 
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